Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0001209191-19-023141

Options or other derivatives

  • Director acquired 4,829 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Ratcliffe Liam · Director

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-04-01 Grant or award : show line 1 in the form Stock Option (Right to Buy) +4,829 $2.72 $13,128 4,829 D
Loading xslF345X03/doc4.xml…